Treatment of mood and behavioral disorders in Alzheimer's Disease (original) (raw)

Behavioral disorders are highly prevalent in patients with Alzheimer's Disease (AD), affecting about 80% of individuals. These disorders encompass a variety of symptoms, including agitation, irritability, aggression, and depression. Recent studies have suggested that acetylcholinesterase inhibitors may help alleviate certain psychotic symptoms associated with AD. Treatment approaches remain largely empirical, requiring careful dosing and frequent reevaluation of therapeutic regimens. The complexity of behavioral disorders in AD complicates treatment, underscoring the need for more rigorous clinical studies to develop effective interventions.